Bridging the evidence and the politics
Implementation trial of supervised injectable opioid treatment (Siot) in Australia
Dados Bibliográficos
| ID | 14906751 |
|---|---|
| Autores | A Ritter (0000-0001-9540-1920, UNSW Sydney, autor correspondente), James Bell (0000-0002-5117-0216, UNSW Sydney), John Strang (0000-0001-9142-210X), Nadine Ezard (0000-0002-7495-8305, National Centre for Clinical Research on Emerging Drugs), Craig Rodgers (0009-0005-1777-2941, Alcohol and Drug Foundation), Vendula Belackova (0000-0002-1334-5425), Marianne Jauncey (0000-0001-9712-5579), Krista J Siefried (0000-0002-6534-3325, National Centre for Clinical Research on Emerging Drugs), Darren M Roberts (0000-0001-9101-7577, Royal Prince Alfred Hospital), Wim Van Den Brink (0000-0001-8301-0121, Amsterdam University Medical Centers), Nicholas Lintzeris (0000-0001-5229-8257, New South Wales Department of Health), Adrian J Dunlop (0000-0003-2394-5966, Hunter New England Local Health District), Adrian Dunlop, Eugenia Oviedo‐Joekes (0000-0002-3566-7097, University of British Columbia), Carla Treloar (0000-0002-8230-0386, UNSW Sydney) |
| Ano | 2025 |
| Volume | 138 |
| Páginas | 104749 |
| Data de publicação | 2025-04-01 |
| Peer Reviewed | Sim |
| Open Access | Sim |
| Tipo | ARTICLE |
| Periódico | International Journal of Drug Policy (JOURNAL) |
| Identificadores do periódico | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editora | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2025.104749 |
| PMID | 40037105 |
| OpenAlex | W4408107997 |
| Idioma | EN |
| Referências citadas | 63 |
Supervised Injectable Opioid Treatment (SIOT) targets people experiencing opioid dependence who have not benefited from existing treatments. In this population, SIOT has been demonstrated to be efficacious and effective, yet this modality of treatment has only been taken up in a few countries. In this commentary we describe the socio-political context and history to the recent establishment of an implementation trial of injectable hydromorphone in Sydney, Australia. These factors influenced choices about the trial design, including integration of SIOT within an existing opioid agonist treatment program, time-limited treatment, and an assessment of feasibility, acceptability, safety and cost. While all new drug policy initiatives occur within a specific socio-political and historical context, we hope this commentary provides reflections for other places considering the introduction of SIOT
Bridging (networking · Computer security · Opioid · Political science · Politics · Computer Science · Health Policy Implementation Science · Law · Medicine · Opioid Use Disorder Treatment · Psychology · Substance Abuse Treatment and Outcomes · Internal Medicine
How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders’ perspectives
Pill testing policy
Heroin-assisted Treatment (HAT) a Decade Later
Federal funding for syringe exchange in the US
In pursuit of safer supply
Prescribing heroin
Experiences with take-home dosing in heroin-assisted treatment in Switzerland during the Covid-19 pandemic–Is an update of legal restrictions warranted
Learning from the past, looking to the future - Is there a place for injectable opioid treatment among Australia’s responses to opioid misuse
Co-located Heroin Assisted Treatment within primary care
Drug consumption rooms
The politics of providing opioid pharmacotherapy
Mapping a moral panic
Producing the ‘problem’ of new psychoactive substances (NPS) in English prisons
Making medicine; producing pleasure
Shouting through bullet-proof glass
Voices represented and voices silenced
The establishment of North America's first state sanctioned supervised injection facility
How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting
Enacting multiple methamphetamines
Emerging adult perceptions of cannabis consumption
Methadone as Social Control
| Velocidade de citação | historical |
|---|---|
| Altamente citado | Não |